Showing 1 posts of 1 posts found.
The Japanese company Astellas Pharma has acquired British gene therapy group Quethera in a deal worth up to £85 million. …
MHRA approves first lower-carbon beclometasone inhalers for asthma
Samsung Biologics launches bid to acquire peptide CDMO PolyPeptide
Novogenia breaks ground on personalised healthcare campus
InfectoPharm launches Polish operations with first hospital antibiotic
FibroFind appoints Lee Borthwick as CEO